Latest News
Featured News
Scancell signs strategic partnership with PharmaJet for use of the Stratis® IM Needle-free delivery System in the development of SCIB1/iSCIB1+ cancer vaccine for Advanced Melanoma
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell progresses its new anti-glycan monoclonal antibody (mAb) platform GlyMab™
Update on COVIDITY Phase 1 clinical trial in South Africa
Interim Results for the 6 months ended 31 October 2021
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.